President | Nonclinical Drug Development | Ocular | Dermal
CurrentAdvises on nonclinical strategies to rapidly move biopharmaceuticals, small molecules, and medical devices from discovery and early development to market, including global development plans, nonclinical study design, and interacting with regulatory agencies and scientific advisers.Key competencies include: -Nonclinical drug and device development strategy and guidance-Ocular, dermal, and neurologic expertise-Toxicology program design and monitoring-Pathology peer reviews-Regulatory submissions and interactions-Due diligence reviews-Nonclinical model design for local delivery therapies